Complete amino acid sequence of human plasma beta 2-glycoprotein I.
about
Amino acid sequence of human plasma alpha 1B-glycoprotein: homology to the immunoglobulin supergene familyPeriodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serumPrimary structure of human complement component C2. Homology to two unrelated protein familiesAnti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipidsHuman homologue of mouse lymph node homing receptor: evolutionary conservation at tandem cell interaction domainsPrimary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placentaIdentification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complementIdentification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteinsHuman C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteinsDimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'Shuffled domains in extracellular proteinsDomain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesisFactor XIII: novel structural and functional aspects.Both kinetic data and epitope mapping provide clues for understanding the anti-coagulant effect of five murine monoclonal antibodies to human beta2-glycoprotein I.Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA.A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor.Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.Activation of cultured vascular endothelial cells by antiphospholipid antibodies.Origin and pathogenesis of antiphospholipid antibodies.Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrinChemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of beta2-glycoprotein I.Evidence for two extracellular domains in the human interleukin-2 receptor: localization of IL-2 binding.Accelerated atheroma and anti-beta2-glycoprotein I antibodies.beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activationMolecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptideGenetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I)Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.Murine protein H is comprised of 20 repeating units, 61 amino acids in length.Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activityAnticardiolipin antibodies and ocular disease.Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system.Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H)Hepatitis B virus surface antigen binds to apolipoprotein H.
P2860
Q24298692-093C546D-8D73-42A6-9C49-C658690E188BQ24300009-E9470D29-C5A3-4991-A0A0-7BDC9E53D6CCQ24529207-E2B16FA0-8024-473A-BC85-91485AB4C665Q24558202-3CA053E6-23C0-4942-AE40-431C1ABF2259Q24561680-EEA8EAAF-C437-4B44-8089-1D2F0B89A844Q24609402-FEAD1781-C179-477B-9F47-AD25E60246F7Q24629218-7287692C-7EA3-4F71-AF08-7AE20A5053BBQ24630380-B6E70C0C-AA88-4240-B048-4746B898E078Q24682397-BB1E17A3-3315-4B22-8323-2BDFF84AFA61Q24682508-F8A84AB5-BE7F-400C-BB3E-642AAFE5351EQ24682687-A2DCEF02-CF81-48B5-84FC-2D758B70A173Q28179249-07973610-B6EF-4A5A-B134-C98A66326EAAQ28288029-903D00BB-4A3C-4CE5-89B6-D31A928DF9CCQ28291393-09824D39-C98B-4375-9F29-89CDE8D2D056Q28740531-F6436B40-C936-468C-92BF-BD99E20048CDQ30156007-0C361030-CD97-46BC-8E6C-B0B5542DA83BQ30580637-5AE9F7E3-A990-410C-A2B2-79DAD9A58703Q33237339-2A830EC8-14FA-4A30-914B-15E1181BF5EFQ33350227-5B5F4967-9DD8-478C-A201-BCC912FD8D6BQ33403225-07962E83-23C3-47C4-91E9-726EEA244549Q33488617-BF840DC1-4902-4D39-9B91-C14ACD3CD3EDQ33503275-AD4CE458-C7B7-4EBA-83AD-AC78AE02EBDDQ33504706-09DB32CD-9614-4382-976E-A277D5E9CF1FQ33511345-EBED3739-5FB3-488E-BCF9-AE8062FC3CD4Q33844273-A44DD603-F125-4F86-A67D-2C6245924E2DQ33881005-FC26FF74-2C37-4DBE-9275-B6A20C71089DQ33915467-29FAC564-4286-4512-92E5-A0FD9AD8C1B4Q34245642-F7BFFCEE-CFB4-4A52-92E5-4901B178A45FQ34556697-A19D399E-BB8F-4A5E-932D-B9E86E542ABEQ35245457-1C3E331C-E02A-4B04-8447-F7B6655AF015Q35419865-7F9EC20A-FC5C-4B7D-AF79-1719F7CF842CQ35609033-90431BFE-71D4-444F-8D8C-DB4ACFCC0D51Q35822631-E6D2D5B5-3308-408C-BF47-547C9358237FQ36157442-C9E1A051-B829-42E5-8532-A47A90FCEB24Q36256231-AAFE953C-C942-4F6F-AE8F-72FDB01F91B1Q36287542-345B474A-C7C1-4C62-A571-02A541DDC92DQ36357106-6DD84975-68C7-44DF-8438-AD2D3609BD57Q36485624-EADA55A8-D0CC-40DB-B4AE-6F6C4B082ACEQ36596956-BED224B1-BBC1-4DD7-901F-8FB951C1FF20Q36632110-3577F94C-2B01-4D80-B9C2-0CF17A5D38A6
P2860
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
@ast
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
@en
type
label
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
@ast
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
@en
prefLabel
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
@ast
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
@en
P2093
P2860
P356
P1476
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.12.3640
P407
P577
1984-06-01T00:00:00Z